Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Behavioural Brain Research|October 11, 2025
Impaired functional neuronal connectivity in schizophrenia negative symptomsJakub Rogalski, Adam WysokińskiPsychiatria Danubina|April 15, 2023
Tolerability and Safety of 219 Transcranial Direct Current Stimulation (TDCS) 2.0 mA Sessions in Adult Patients with SchizophreniaAdam WysokińskiNordic Journal of Psychiatry|November 10, 2015
Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophreniaAdam WysokińskiDiabetes & Metabolic Syndrome|October 15, 2014
Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapyAdam WysokińskiClinical Neuropharmacology|January 13, 2015
Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapyAdam WysokińskiPostepy Psychiatrii Neurologii|December 16, 2024
Ferroptosis as a potential connection between schizophrenia and metabolic dysfunction-associated steatotic liver disease - a narrative reviewJakub Rogalski, Tomasz TomczakNeurochemical Research|July 23, 2013
Homocysteine levels in patients with schizophrenia on clozapine monotherapyAdam Wysokiński, Iwona KłoszewskaPsychiatry Research|September 16, 2014
Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapyAdam Wysokiński, Iwona KłoszewskaPsychiatry Research|January 26, 2016
Platelet parameters (PLT, MPV, P-LCR) in patients with schizophrenia, unipolar depression and bipolar disorderAdam Wysokiński, Ewa SzczepockaThe Chinese Journal of Physiology|November 1, 2019
Association between adiposity and fasting serum levels of appetite-regulating peptides: Leptin, neuropeptide Y, desacyl ghrelin, peptide YY(1-36), obestatin, cocaine and amphetamine-regulated transcript, and agouti-related protein in nonobese participantsAnna Lucka, Adam WysokińskiPageof 7